| Company Name: |
HitGen Inc. Gold |
| Tel: |
028-85197385 18628204893 |
| Email: |
jc.tang@hitgen.com |
TT3-LLN manufacturers
- TT3
-
-
2026-07-24
- CAS:1821214-50-9
- Min. Order: 1g
- Purity: 98%
- Supply Ability: 1g/bottle , 10g/bottle, 100g/bottle
|
| | TT3-LLN Basic information |
| Product Name: | TT3-LLN | | Synonyms: | TT3-LLN;N1,N3,N5-tris(3-(didocecylamino)propyl)benzene-1,3,5-tricarboxamide;N1,N3,N5-tris(3-(didodecylamino)propyl)benzene-1,3,5-tricarboxamide | | CAS: | 1821214-50-9 | | MF: | C90H174N6O3 | | MW: | 1388.42 | | EINECS: | | | Product Categories: | | | Mol File: | 1821214-50-9.mol |  |
| | TT3-LLN Chemical Properties |
| solubility | Ethanol: Soluble | | form | Oil | | color | Light yellow to yellow | | InChIKey | KIOSQLHXJYTPDN-UHFFFAOYSA-N | | SMILES | C(C1C=C(C(=O)NCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC)C=C(C(=O)NCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC)C=1)(=O)NCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC |
| | TT3-LLN Usage And Synthesis |
| Uses | TT3 is an ionizable lipid-like materials for mRNA delivery[1][2]. | | References | [1] Li B, Luo X, Deng B, et al. An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo. Nano Lett. 2015;15(12):8099-8107. DOI:10.1021/acs.nanolett.5b03528
[2] Jiang C, Mei M, Li B, et al. A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo. Cell Res. 2017;27(3):440-443. DOI:10.1038/cr.2017.16 |
| | TT3-LLN Preparation Products And Raw materials |
|